Screener
Ultragenyx Pharmaceutical RARE Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Ultragenyx Pharmaceutical’s reported figures.
Based on trailing twelve months.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's asset turnover?
- Ultragenyx Pharmaceutical (RARE) reported asset turnover of 0.6× in Q2 2026.
- How has Ultragenyx Pharmaceutical's asset turnover changed year-over-year?
- Ultragenyx Pharmaceutical's asset turnover increased by 33.8% year-over-year, from 0.4× to 0.6×.
- What is the long-term trend for Ultragenyx Pharmaceutical's asset turnover?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's asset turnover has grown at a 18.8% compound annual growth rate (CAGR), from 0.2× to 0.4×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Ultragenyx Pharmaceutical's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude